Pharmacophore modeling technique applied for the discovery of proteasome inhibitors.

about

Computational Approaches for the Discovery of Human Proteasome Inhibitors: An Overview Hybrid Receptor-Bound/MM-GBSA-Per-residue Energy-Based Pharmacophore Modelling: Enhanced Approach for Identification of Selective LTA4H Inhibitors as Potential Anti-inflammatory Drugs.

P2860

Q26738752-FB681059-36D1-49FC-80A1-0521CCEBD7C4 Q46213251-4A736B4C-FD0A-40EA-A904-06839AC5D923

P2860

Pharmacophore modeling technique applied for the discovery of proteasome inhibitors.

Item

http://www.wikidata.org/entity/Q38216045

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Pharmacophore modeling technique applied for the discovery of proteasome inhibitors.

@en

type

Item

label

Pharmacophore modeling technique applied for the discovery of proteasome inhibitors.

@en

prefLabel

Pharmacophore modeling technique applied for the discovery of proteasome inhibitors.

@en

P1476

Pharmacophore modeling technique applied for the discovery of proteasome inhibitors.

@en

P2093

Chiara Pautasso

http://www.w3.org/2001/XMLSchema#string

Mariella Genuardi

http://www.w3.org/2001/XMLSchema#string

Rossella Troia

http://www.w3.org/2001/XMLSchema#string

P2860

Proteasome inhibition by fellutamide B induces nerve growth factor synthesis

Applied techniques for mining natural proteasome inhibitors

Crystal structure of the 20 S proteasome:TMC-95A complex: a non-covalent proteasome inhibitor

A plant pathogen virulence factor inhibits the eukaryotic proteasome by a novel mechanism

Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S β5-subunit

Hydroxyureas as noncovalent proteasome inhibitors

Immuno- and constitutive proteasome crystal structures reveal differences in substrate and inhibitor specificity

Dimerized linear mimics of a natural cyclopeptide (TMC-95A) are potent noncovalent inhibitors of the eukaryotic 20S proteasome

Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution

Structure of 20S proteasome from yeast at 2.4 A resolution

P304

931-943

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17460441.2014.923838

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Antonio Palumbo

P577

2014-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24877566

http://www.w3.org/2001/XMLSchema#string

Pharmacophore modeling technique applied for the discovery of proteasome inhibitors.

about

P2860

P2860

Pharmacophore modeling technique applied for the discovery of proteasome inhibitors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698